Titre : Fibrose

Fibrose : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Fibrose : Questions médicales les plus fréquentes", "headline": "Fibrose : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Fibrose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-06", "dateModified": "2025-04-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Fibrose" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Processus pathologiques", "url": "https://questionsmedicales.fr/mesh/D010335", "about": { "@type": "MedicalCondition", "name": "Processus pathologiques", "code": { "@type": "MedicalCode", "code": "D010335", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cicatrice hypertrophique", "alternateName": "Cicatrix, Hypertrophic", "url": "https://questionsmedicales.fr/mesh/D017439", "about": { "@type": "MedicalCondition", "name": "Cicatrice hypertrophique", "code": { "@type": "MedicalCode", "code": "D017439", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.274.505" } } }, { "@type": "MedicalWebPage", "name": "Chéloïde", "alternateName": "Keloid", "url": "https://questionsmedicales.fr/mesh/D007627", "about": { "@type": "MedicalCondition", "name": "Chéloïde", "code": { "@type": "MedicalCode", "code": "D007627", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.274.510" } } }, { "@type": "MedicalWebPage", "name": "Adhérences tissulaires", "alternateName": "Tissue Adhesions", "url": "https://questionsmedicales.fr/mesh/D000267", "about": { "@type": "MedicalCondition", "name": "Adhérences tissulaires", "code": { "@type": "MedicalCode", "code": "D000267", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.274.840" } } }, { "@type": "MedicalWebPage", "name": "Cirrhose du foie", "alternateName": "Liver Cirrhosis", "url": "https://questionsmedicales.fr/mesh/D008103", "about": { "@type": "MedicalCondition", "name": "Cirrhose du foie", "code": { "@type": "MedicalCode", "code": "D008103", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.412" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cirrhose biliaire", "alternateName": "Liver Cirrhosis, Biliary", "url": "https://questionsmedicales.fr/mesh/D008105", "about": { "@type": "MedicalCondition", "name": "Cirrhose biliaire", "code": { "@type": "MedicalCode", "code": "D008105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.412.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Fibrose systémique néphrogénique", "alternateName": "Nephrogenic Fibrosing Dermopathy", "url": "https://questionsmedicales.fr/mesh/D054989", "about": { "@type": "MedicalCondition", "name": "Fibrose systémique néphrogénique", "code": { "@type": "MedicalCode", "code": "D054989", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.550" } } }, { "@type": "MedicalWebPage", "name": "Fibrose péritonéale", "alternateName": "Peritoneal Fibrosis", "url": "https://questionsmedicales.fr/mesh/D056627", "about": { "@type": "MedicalCondition", "name": "Fibrose péritonéale", "code": { "@type": "MedicalCode", "code": "D056627", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.625" } } }, { "@type": "MedicalWebPage", "name": "Fibrose pulmonaire", "alternateName": "Pulmonary Fibrosis", "url": "https://questionsmedicales.fr/mesh/D011658", "about": { "@type": "MedicalCondition", "name": "Fibrose pulmonaire", "code": { "@type": "MedicalCode", "code": "D011658", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.644" } } }, { "@type": "MedicalWebPage", "name": "Fibrose rétropéritonéale", "alternateName": "Retroperitoneal Fibrosis", "url": "https://questionsmedicales.fr/mesh/D012185", "about": { "@type": "MedicalCondition", "name": "Fibrose rétropéritonéale", "code": { "@type": "MedicalCode", "code": "D012185", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.355.700" } } } ], "about": { "@type": "MedicalCondition", "name": "Fibrose", "alternateName": "Fibrosis", "code": { "@type": "MedicalCode", "code": "D005355", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nikolaos G Frangogiannis", "url": "https://questionsmedicales.fr/author/Nikolaos%20G%20Frangogiannis", "affiliation": { "@type": "Organization", "name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, USA. Electronic address: nikolaos.frangogiannis@einsteinmed.org." } }, { "@type": "Person", "name": "Pierre-Régis Burgel", "url": "https://questionsmedicales.fr/author/Pierre-R%C3%A9gis%20Burgel", "affiliation": { "@type": "Organization", "name": "Université Paris Cité and Institut Cochin, Inserm U1016, Paris, France." } }, { "@type": "Person", "name": "Jane C Davies", "url": "https://questionsmedicales.fr/author/Jane%20C%20Davies", "affiliation": { "@type": "Organization", "name": "National Heart & Lung Institute, Imperial College London, London, UK." } }, { "@type": "Person", "name": "Na Liu", "url": "https://questionsmedicales.fr/author/Na%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Nanjing, Jiangsu, China." } }, { "@type": "Person", "name": "Ruoshui Li", "url": "https://questionsmedicales.fr/author/Ruoshui%20Li", "affiliation": { "@type": "Organization", "name": "The Wilf Family Cardiovascular Research Institute, Department of Medicine (Cardiology), Albert Einstein College of Medicine, Bronx, NY, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Protocol for a multicenter-cluster randomized clinical trial of a motor skills intervention to promote physical activity and health in children: the CHAMP afterschool program study.", "datePublished": "2022-08-13", "url": "https://questionsmedicales.fr/article/35964114", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12889-022-13849-8" } }, { "@type": "ScholarlyArticle", "name": "Examining the associations between PTSD symptom clusters and alcohol-related problems in a sample of low-SES treatment-seeking Black/African American adults.", "datePublished": "2022-08-04", "url": "https://questionsmedicales.fr/article/35963024", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jpsychires.2022.07.060" } }, { "@type": "ScholarlyArticle", "name": "A workplace organisational intervention to improve hospital nurses' and physicians' mental health: study protocol for the Magnet4Europe wait list cluster randomised controlled trial.", "datePublished": "2022-07-28", "url": "https://questionsmedicales.fr/article/35902190", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2021-059159" } }, { "@type": "ScholarlyArticle", "name": "Dosimetry assessment of theranostic Auger-emitting radionuclides in a micron-sized multicellular cluster model: A Monte Carlo study using Geant4-DNA simulations.", "datePublished": "2022-07-12", "url": "https://questionsmedicales.fr/article/35868198", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.apradiso.2022.110380" } }, { "@type": "ScholarlyArticle", "name": "Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35816831", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.yebeh.2022.108811" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Fibrose", "item": "https://questionsmedicales.fr/mesh/D005355" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Fibrose - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Fibrose", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Fibrose", "description": "Comment diagnostique-t-on la fibrose pulmonaire ?\nQuels tests sanguins sont utiles pour la fibrose ?\nLa fibrose peut-elle être détectée par échographie ?\nQuels sont les signes radiologiques de la fibrose ?\nLa fibrose peut-elle être confondue avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Fibrose", "description": "Quels sont les symptômes de la fibrose pulmonaire ?\nLa fibrose hépatique provoque-t-elle des douleurs ?\nQuels signes indiquent une fibrose cardiaque ?\nLa fibrose peut-elle entraîner une perte de poids ?\nQuels symptômes sont associés à la fibrose systémique ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Fibrose", "description": "Comment prévenir la fibrose pulmonaire ?\nPeut-on prévenir la fibrose hépatique ?\nLes examens réguliers aident-ils à prévenir la fibrose ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe contrôle des maladies chroniques aide-t-il ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Fibrose", "description": "Quels traitements existent pour la fibrose pulmonaire ?\nLa chirurgie est-elle une option pour la fibrose ?\nQuels médicaments sont utilisés pour la fibrose hépatique ?\nLa physiothérapie aide-t-elle en cas de fibrose ?\nY a-t-il des traitements naturels pour la fibrose ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Fibrose", "description": "Quelles sont les complications de la fibrose pulmonaire ?\nLa fibrose hépatique peut-elle entraîner une cirrhose ?\nQuels risques sont associés à la fibrose cardiaque ?\nLa fibrose peut-elle affecter la qualité de vie ?\nY a-t-il des complications psychologiques liées à la fibrose ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Fibrose", "description": "Quels sont les facteurs de risque de la fibrose pulmonaire ?\nL'âge est-il un facteur de risque pour la fibrose ?\nLes maladies auto-immunes augmentent-elles le risque de fibrose ?\nLe diabète est-il un facteur de risque pour la fibrose hépatique ?\nL'exposition professionnelle influence-t-elle le risque de fibrose ?", "url": "https://questionsmedicales.fr/mesh/D005355?mesh_terms=Cluster+Analysis&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on la fibrose pulmonaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens d'imagerie, des tests fonctionnels pulmonaires et parfois une biopsie." } }, { "@type": "Question", "name": "Quels tests sanguins sont utiles pour la fibrose ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests pour évaluer les marqueurs inflammatoires et la fonction hépatique peuvent être effectués." } }, { "@type": "Question", "name": "La fibrose peut-elle être détectée par échographie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'échographie peut aider à visualiser la fibrose dans certains organes comme le foie." } }, { "@type": "Question", "name": "Quels sont les signes radiologiques de la fibrose ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des opacités, des réticulations et des anomalies de la structure tissulaire." } }, { "@type": "Question", "name": "La fibrose peut-elle être confondue avec d'autres maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être confondue avec des maladies comme la pneumonie ou la cirrhose." } }, { "@type": "Question", "name": "Quels sont les symptômes de la fibrose pulmonaire ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent une toux persistante, un essoufflement et une fatigue chronique." } }, { "@type": "Question", "name": "La fibrose hépatique provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer des douleurs abdominales et une sensation de lourdeur dans l'abdomen." } }, { "@type": "Question", "name": "Quels signes indiquent une fibrose cardiaque ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des palpitations, un essoufflement à l'effort et des œdèmes." } }, { "@type": "Question", "name": "La fibrose peut-elle entraîner une perte de poids ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fibrose peut causer une perte de poids due à une mauvaise absorption des nutriments." } }, { "@type": "Question", "name": "Quels symptômes sont associés à la fibrose systémique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs articulaires, une raideur cutanée et des troubles circulatoires." } }, { "@type": "Question", "name": "Comment prévenir la fibrose pulmonaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme, réduire l'exposition à des polluants et traiter les infections respiratoires." } }, { "@type": "Question", "name": "Peut-on prévenir la fibrose hépatique ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en adoptant un mode de vie sain, en évitant l'alcool et en se vaccinant contre l'hépatite." } }, { "@type": "Question", "name": "Les examens réguliers aident-ils à prévenir la fibrose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent détecter précocement des maladies pouvant mener à la fibrose." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée riche en antioxydants peut aider à prévenir la fibrose." } }, { "@type": "Question", "name": "Le contrôle des maladies chroniques aide-t-il ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, bien gérer des maladies comme le diabète ou l'hypertension peut réduire le risque de fibrose." } }, { "@type": "Question", "name": "Quels traitements existent pour la fibrose pulmonaire ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments antifibrotiques, la réhabilitation pulmonaire et l'oxygénothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle une option pour la fibrose ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans certains cas avancés, une transplantation d'organe peut être envisagée." } }, { "@type": "Question", "name": "Quels médicaments sont utilisés pour la fibrose hépatique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments pour traiter la cause sous-jacente, comme les antiviraux pour l'hépatite, sont utilisés." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle en cas de fibrose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut améliorer la fonction pulmonaire et la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour la fibrose ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches comme les antioxydants peuvent aider, mais il faut consulter un médecin." } }, { "@type": "Question", "name": "Quelles sont les complications de la fibrose pulmonaire ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire, les infections pulmonaires et les embolies." } }, { "@type": "Question", "name": "La fibrose hépatique peut-elle entraîner une cirrhose ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fibrose hépatique peut évoluer vers une cirrhose, entraînant des complications graves." } }, { "@type": "Question", "name": "Quels risques sont associés à la fibrose cardiaque ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent l'insuffisance cardiaque, les arythmies et les accidents vasculaires cérébraux." } }, { "@type": "Question", "name": "La fibrose peut-elle affecter la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut réduire la qualité de vie en limitant les activités quotidiennes et en causant de la douleur." } }, { "@type": "Question", "name": "Y a-t-il des complications psychologiques liées à la fibrose ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent éprouver de l'anxiété et de la dépression en raison de leur état de santé." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de la fibrose pulmonaire ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des substances toxiques et des infections antérieures." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour la fibrose ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de fibrose augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "Les maladies auto-immunes augmentent-elles le risque de fibrose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme la sclérodermie peuvent prédisposer à la fibrose dans divers organes." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque pour la fibrose hépatique ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut augmenter le risque de fibrose hépatique en raison de la stéatose." } }, { "@type": "Question", "name": "L'exposition professionnelle influence-t-elle le risque de fibrose ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des professions exposant à des poussières ou des produits chimiques peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Protocol for a multicenter-cluster randomized clinical trial of a motor skills intervention to promote physical activity and health in children: the CHAMP afterschool program study.

Promoting health-enhancing and sustainable physical activity levels across childhood and adolescence contribute to positive health outcomes as an adult. This study will aim to: a) examine the immediat... This multicenter cluster randomized trial will be implemented by ASP staff and will be conducted in ASPs located in two city-based cohorts: East Lansing/Lansing and Ann Arbor/Ypsilanti, Michigan. Chil... The long-term goal is to provide a sustainable, ecologically-relevant, and evidence-based program during the early elementary years that can be delivered by ASP staff, is health-enhancing, and increas... ClinicalTrials.gov Identifier NCT05342701 .... Ethical approval was obtained through the Health Sciences and Behavioral Sciences IRB, University of Michigan (HUM00208311). The CHAMP-ASP study is funded by the National Institutes of Health. Finding...

Examining the associations between PTSD symptom clusters and alcohol-related problems in a sample of low-SES treatment-seeking Black/African American adults.

Posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) often co-occur. This comorbidity negatively influences treatment outcomes, functioning, and quality of life. To better understand th...

A workplace organisational intervention to improve hospital nurses' and physicians' mental health: study protocol for the Magnet4Europe wait list cluster randomised controlled trial.

The increasing burden of mental distress reported by healthcare professionals is a matter of serious concern and there is a growing recognition of the role of the workplace in creating this problem. M... Magnet4Europe is a cluster randomised controlled trial, with wait list controls, designed to evaluate the effects of organisational redesign, based on the Magnet model, on nurses' and physicians' well... This study was approved by the Ethics Committee Research UZ/KU Leuven, Belgium; additionally, ethics approval is obtained in all other participating countries either through a central or decentral aut... ISRCTN10196901....

Quality-of-life results in adults with epilepsy using diazepam nasal spray for seizure clusters from a long-term, open-label safety study.

The impact of seizure clusters and the use of intermittent rescue therapy for clusters on the quality of life (QoL) of patients with epilepsy has not been widely studied. The present analysis assessed... The 12-month safety study of diazepam nasal spray enrolled patients aged 6-65 years with seizure clusters. Adults aged ≥18 years completed the Quality of Life in Epilepsy (QOLIE)-31-P at baseline (day... Seventy-two adults who responded to the QOLIE-31-P were included in the analyses. Mean QOLIE-31-P scores were stable or increased across time points. The mean total scores increased from day 0 to day ... Adults with refractory epilepsy who were treated with diazepam nasal spray for seizure clusters maintained or improved QOLIE subscale scores across the 12-month study period. Seizure Worry and Social ...

Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.

To promote the identification of women carrying BRCA1/2 variants, the US Preventive Services Task Force recommends that primary care clinicians screen asymptomatic women for an increased risk of carry... To examine the effects of patient and clinician decision support about BRCA1/2 genetic testing compared with standard education alone.... This clustered randomized clinical trial was conducted at an academic medical center including 67 clinicians (unit of randomization) and 187 patients. Patient eligibility criteria included women aged ... RealRisks decision aid for patients and the Breast Cancer Risk Navigation Tool decision support for clinicians. Patients scheduled a visit with their clinician within 6 months of enrollment.... The primary end point was genetic counseling uptake at 6 months. Secondary outcomes were genetic testing uptake at 6 and 24 months, decision-making measures (perceived breast cancer risk, breast cance... From December 2018 to February 2020, 187 evaluable patients (101 in the intervention group, 86 in the control group) were enrolled (mean [SD] age: 40.7 [13.2] years; 88 Hispanic patients [46.6%]; 15 n... This randomized clinical trial did not find a significant increase in genetic counseling uptake among patients who received patient and clinician decision support vs those who received standard educat... ClinicalTrials.gov Identifier: NCT03470402....

Feasibility and acceptability of a multicomponent, group psychological intervention for adolescents with psychosocial distress in public schools of Pakistan: a feasibility cluster randomized controlled trial (cRCT).

Child and adolescent mental health problems are a global public mental health priority. However, there is a lack of evidence-based scalable psychological interventions for adolescents living in low re... A two arm, single blinded, feasibility cluster randomized controlled trial with mixed-methods evaluation was conducted with 59 adolescents and their caregivers from 8 public schools. In the 4 interven... The participation rate of adolescents in the intervention sessions was 83%. The intervention strategies were implemented by the adolescents. However, attending biweekly sessions at schools was challen... The results of this study support the feasibility and acceptability of delivering this culturally adapted intervention through non-specialist facilitators in school settings in Pakistan and pave the w...

The Short-Term Impact of a Combination Intervention on Depressive Symptoms Among School-Going Adolescent Girls in Southwestern Uganda: The Suubi4Her Cluster Randomized Trial.

This study aims to examine the short-term impact of a combined intervention consisting of evidence-based family economic empowerment (FEE) and multiple family group (MFG) interventions on depressive s... We analyzed longitudinal data from a cluster randomized trial. The sample consisted of 1,260 adolescent girls (aged 14-17 years at enrollment) recruited from senior one and senior two classes across 4... At baseline, there were no significant differences between the control condition and both treatment conditions. While all three groups experienced a substantial reduction in depressive symptoms from b... Results imply that the FEE intervention may be a promising tool in addressing depressive symptoms among adolescent girls. Therefore, to reduce the long-term implications of adverse psychosocial health...